Reuters |
FDA panel backs approval of GSK asthma drug in adults
Reuters An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older. The panel voted 10 to 4 against approving it in children aged … UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in … FDA committee recommends approval of Nucala for adults with severe asthma |
View full post on asthma – Google News